You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Transarterial Chemoembolization

Showing 1 - 25 of 589
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CT Imaging for Guiding PA-TACE for HCC

Recruiting
  • Carcinoma, Hepatocellular
  • postoperative adjuvant transarterial chemoembolization
  • Guangzhou, Guangdong, China
    ZhuJiang Hospital of Southern Medical University
Nov 30, 2023

HepaSphere Transarterial Chemoembolization Combined With Hepatic

Not yet recruiting
  • Colorectal Liver Metastases (CRCLM)
  • DEB-TACE plus HAIC
  • Beijing, Beijing, China
    Beijing Cancer Hospital
May 25, 2023

HepaSphere Drug-eluting Bead Transarterial Chemoembolization

Recruiting
  • Advanced Hepatocellular Carcinoma (HCC)
  • DEB-TACE plus HAIC or HAIC alone
  • Beijing, Beijing, China
    Beijing Cancer Hospital
May 19, 2023

Hepatocellular Carcinoma Trial in Nanning (Transarterial chemoembolization, Radiotherapy)

Recruiting
  • Hepatocellular Carcinoma
  • Transarterial chemoembolization
  • Radiotherapy
  • Nanning, Guangxi, China
    Department of Hepatobilliary Surgery, Affiliated Tumor of Guangx
Jan 25, 2023

Hepatocellular Carcinoma Trial in New Delhi (N Acetylcysteine, Dexamethasone, Placebo)

Not yet recruiting
  • Hepatocellular Carcinoma
  • N Acetylcysteine
  • +2 more
  • New Delhi, Delhi, India
    Institute of Liver & Biliary Sciences
Sep 8, 2023

Antibiotic Prophylaxis Trial in Lahore (Ceftriaxone Sodium)

Recruiting
  • Antibiotic Prophylaxis
  • Ceftriaxone Sodium
  • Lahore, Punjab, Pakistan
    Pakistan Kidney and Liver Institute
Dec 8, 2022

Gastric Cancer, Embolization Trial (Transarterial Chemoembolization)

Not yet recruiting
  • Gastric Cancer
  • Embolization
  • Transarterial Chemoembolization
  • (no location specified)
May 17, 2022

Child-Pugh Class A, Child-Pugh Class B, Recurrent Hepatocellular Carcinoma Trial in Palo Alto, Sapporo (radiation, procedure,

Active, not recruiting
  • Child-Pugh Class A
  • +2 more
  • Stereotactic Body Radiation Therapy
  • +3 more
  • Palo Alto, California
  • +1 more
Sep 9, 2022

Carcinoma, Hepatocellular, Hepatic Carcinoma, Hepatocellular Cancer Trial in Hannover (Nivolumab, TACE)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • +2 more
  • Hannover, Germany
    Medizinische Hochschule Hannover, Klinik für Gastroenterologie,
Nov 21, 2022

Hepatocellular Carcinoma, Bilirubinemia Trial in Minneapolis (Transarterial chemoembolization)

Completed
  • Hepatocellular Carcinoma
  • Bilirubinemia
  • Transarterial chemoembolization
  • Minneapolis, Minnesota
    University of Minnesota
Mar 18, 2022

Advanced Hepatocellular Carcinoma Trial in Guangzhou (drug, procedure, radiation)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Oct 20, 2022

Hepatocellular Cancer, Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma Trial run by the NCI (durvalumab,

Recruiting
  • Hepatocellular Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Hepatocellular Carcinoma, Liver Cancer Trial in Seoul (IDA-TACE, DOX-TACE)

Recruiting
  • Hepatocellular Carcinoma
  • Liver Cancer
  • IDA-TACE
  • DOX-TACE
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Oct 27, 2023

Lung Non-Small Cell Carcinoma, Mediastinal Tumor, Pleural Tumor Trial in Duarte (Angiography, Computed Tomography, Ethiodized

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • +2 more
  • Angiography
  • +5 more
  • Duarte, California
    City of Hope Medical Center
Jan 3, 2023

Hepatocellular Carcinoma Trial in Nanjing (cTACE(conventional transarterial chemoembolization))

Recruiting
  • Hepatocellular Carcinoma
  • cTACE(conventional transarterial chemoembolization)
  • Nanjing, Jiangsu, China
    Zhongda Hospital, Southeast University
Dec 28, 2022

Hepatocellular Carcinoma Non-resectable, Transarterial Chemoembolization, Tyrosine Kinase Inhibitor Trial in Chengdu (lenvatinib

Enrolling by invitation
  • Hepatocellular Carcinoma Non-resectable
  • +3 more
  • lenvatinib + sindilimab/carrelizumab
  • TACE
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
May 23, 2022

Thrombocytopenia, Hepatocellular Carcinoma Trial in Guangzhou (Avatrombopag)

Not yet recruiting
  • Thrombocytopenia
  • Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Aug 17, 2023

Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma, Stage IV Choroidal and Ciliary Body Melanoma AJCC V8 Trial

Recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson Univeristy
Nov 16, 2022

Colorectal Cancer Trial (TACE protocol, Neoadjuvant Chemotherapy)

Not yet recruiting
  • Colorectal Cancer
  • TACE protocol
  • Neoadjuvant Chemotherapy
  • (no location specified)
Apr 15, 2022

Hepatocellular Carcinoma Trial in Yantai

Completed
  • Hepatocellular Carcinoma
    • Yantai, Shandong, China
      Yuhuangding Hospital
    Sep 16, 2022

    Primary Liver Cancer Trial in Shanghai (Embosphere and chemo drug, Polyvinyl alcohol embolization microspheres (Huihe Medical)

    Enrolling by invitation
    • Primary Liver Cancer
    • Embosphere and chemotherapy drug
    • Polyvinyl alcohol embolization microspheres (Huihe Medical) and chemotherapy drug
    • Shanghai, Shanghai, China
      Shanghai Huihe Healthcare Tecnology Co.,Ltd.
    Mar 5, 2023

    Intermediate Stage of Hepatocellular Carcinoma, Hepatocellular Carcinoma Trial in Baltimore (Durvalumab, Tremelimumab (Cohort A

    Recruiting
    • Intermediate Stage of Hepatocellular Carcinoma
    • Hepatocellular Carcinoma
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center
    Oct 6, 2022

    Hepatocellular Carcinoma Resectable Trial in Fuzhou (neoadjuvant therapy)

    Not yet recruiting
    • Hepatocellular Carcinoma Resectable
    • neoadjuvant therapy
    • Fuzhou, Fujian, China
      The First Affiliated Hospital of Fujian Medical University
    Aug 19, 2023

    Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma Trial (Atezolizumab Injection, Bevacizumab, Transarterial

    Not yet recruiting
    • Hepatocellular Carcinoma
    • BCLC Stage B Hepatocellular Carcinoma
    • Atezolizumab Injection
    • +2 more
    • (no location specified)
    Mar 16, 2023

    Inoperable Hepatocellular Carcinoma Trial in Nanjing (TheraSphere™ Yttrium-90 Glass Microspheres, conventional Transarterial

    Recruiting
    • Inoperable Hepatocellular Carcinoma
    • TheraSphere™ Yttrium-90 Glass Microspheres
    • conventional Transarterial Chemoembolization(cTACE)
    • Nanjing, Jiangsu, China
      Zhongda Hospital Southeast University
    Jul 22, 2022